Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
BALAMINES

Balaji Amines Share Price

 

 

Balaji Amines live price: ₹1747.9. It opened at ₹1,746 vs previous close ₹1,763; intraday high/low: ₹1,780/₹1,702. The 50 & 200 DMA stand at ₹1,274.13/₹1,289.30.

Balaji Amines Performance

  • Today's Low
  • ₹1,702
  • Today's High
  • ₹1,780
  • 52 Week Low
  • ₹968
  • 52 Week High
  • ₹1,945
  • Open Price₹1,746
  • Previous Close₹1,763
  • Volume372,089
  • 50 DMA₹1,274.13
  • 100 DMA₹1,229.68
  • 200 DMA₹1,289.30

Balaji Amines Chart

Investment Returns

  • Over 1 Month + 53.42%
  • Over 3 Month + 58.35%
  • Over 6 Month + 46.3%
  • Over 1 Year + 24.54%

Smart Investing Starts Here Start SIP with Balaji Amines for Steady Growth!

Invest Now

Balaji Amines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 34
  • PEG Ratio
  • 6
  • Market Cap Cr
  • 5,663
  • P/B Ratio
  • 3
  • Average True Range
  • 91.01
  • EPS
  • 51.6
  • Dividend Yield
  • 0.6
  • MACD Signal
  • 100.57
  • RSI
  • 77.41
  • MFI
  • 93.55

Balaji Amines Financials

Balaji Amines Technicals

EMA & SMA

Current Price
₹1,747.90
-15.1 (-0.86%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,421.76
  • 50 Day
  • ₹1,274.13
  • 100 Day
  • ₹1,229.68
  • 200 Day
  • ₹1,289.30

Resistance and Support

1725.77 Pivot Speed
  • R3 2,005.83
  • R2 1,900.07
  • R1 1,831.53
  • S1 1,657.23
  • S2 1,551.47
  • S3 1,482.93

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Balaji Amines Ltd., is a leading ISO 9001:2015 certified manufacturer of Methylamines, Ethylamines, Specialty Chemicals, and Pharma Excipients. The company is renowned for its advanced manufacturing and R&D capabilities.

Balaji Amines Limited has an operating revenue of Rs. 1,424.98 Cr. on a trailing 12-month basis. An annual revenue growth of 2% is not great, Pre-tax margin of 16% is great, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 45% and 33% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 48 which is a POOR score indicating inconsistency in earnings, a RS Rating of 92 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 48 indicates it belongs to a fair industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Balaji Amines Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-13 Audited Results & Final Dividend
2026-01-29 Quarterly Results
2025-11-10 Quarterly Results
2025-08-02 Quarterly Results
2025-05-28 Audited Results & Final Dividend (Revised) per share(200%)Final Dividend
Date Purpose Remarks
2025-08-01 FINAL Rs.11.00 per share(550%)Final Dividend
View Balaji Amines Dividend History Arrow

Balaji Amines Shareholding Pattern

54.59%
0.12%
1.33%
2.99%
0%
35.73%
5.24%

Balaji Amines FAQs

Balaji Amines share price is ₹1,747 As on 19 May, 2026 | 14:05

The Market Cap of Balaji Amines is ₹5663.4 Cr As on 19 May, 2026 | 14:05

The P/E ratio of Balaji Amines is 34 As on 19 May, 2026 | 14:05

The PB ratio of Balaji Amines is 3 As on 19 May, 2026 | 14:05

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23